If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCAP-XX Regulatory News (CPX)

Share Price Information for CAP-XX (CPX)

Share Price is delayed by 15 minutes
Get Live Data
0.29    -0.01 (-3.33%)
Bid:
0.28
Ask:
0.30
Spread: 0.02 (7.143%)
Market Cap: £16.81m
CPX Live PriceLast checked at - London Stock Exchange

Intraday CAP-XX Share Chart

Directorate Change

9 May 2007 07:02

CAP-XX Limited09 May 2007 CAP-XX Appoints Brett Sandercock as Non-Executive Director Sydney, Australia - May 9, 2007 - CAP-XX Limited, a world leader in the designand manufacture of thin-form supercapacitors and energy management systems,today announces that it has appointed Bret Sandercock as a Non-ExecutiveDirector and Chairman of the audit committee. Brett Sandercock is Chief Financial Officer of ResMed (NYSE: RMD and ASX:RMD.AX), a US medtech company recognised by Forbes as one of the Best SmallCompanies in the US for the 10th year in a row. Prior to joining ResMEd in 1998he worked as Manager, Financial Accounting and Group Reporting at NortonAbrasives, a division of the French multi-national, Saint Gobain. Anthony Kongats, CEO of CAP-XX, said: "Brett is an excellent addition to our non-executive team. At ResMed he has beenpart of the team that has stewarded the company through a period of tremendousgrowth. His expertise and counsel will be a valuable asset to the Company as wecontinue to make good progress in advancing our discussions with the world'sleading mobile hand set manufacturers." For further information contact: CAP-XXAnthony Kongats, Chief Executive Officer +61 (0) 2 9428 0139 Gavin Anderson & Company (Financial PR)Robert Speed / Deborah Walter +44 (0) 20 7554 1400 Collins Stewart (Nomad)Tim Mickley +44 (0) 20 7523 8000 Notes to Editors: CAP-XX is a world leader in the design and manufacture of thin formsupercapacitors and energy management systems, predominantly for portableelectronic devices. The unique feature of CAP-XX's supercapacitors is their ability to store highvolumes of energy and output high power levels within a thin form design. Theseattributes will be critical for the next generation of high volume, power-hungryportable electronic devices, including mobile phones. Portable devices are one of the fastest growing segments of the electronicsmarket and provide the greatest opportunities for CAP-XX's products. CAP-XX'sproducts are already an established enabling technology for the currentgeneration of wireless devices, such as PDAs and PCMCIA cards. More information is available at www.cap-xx.com This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
2nd Jul 20197:00 amRNSUS court action settlement and licence agreement
25th Jun 201910:45 amRNSIssue of Shares and Director/PDMR Shareholdings
7th Jun 20198:59 amRNSHolding(s) in Company
6th Jun 20199:03 amRNSTrading Update
30th May 20198:27 amRNSHolding(s) in Company
17th Apr 20193:09 pmRNSHolding(s) in Company
16th Apr 20197:00 amRNSTrading Update
6th Mar 20197:00 amRNSInterim Results
1st Mar 20197:36 amRNSDirector Disclosure Update
22nd Jan 20198:32 amRNSHolding(s) in Company
20th Dec 20188:43 amRNSIssue of Shares and Director/PDMR Shareholdings
20th Nov 20188:29 amRNSResult of AGM and Chairman's AGM statement
14th Nov 20187:00 amRNSHolding(s) in Company
5th Nov 20187:00 amRNSSubscription to raise £1.75 million
23rd Oct 20187:00 amRNSExercise of share options & PDMR shareholding
22nd Oct 201810:09 amRNSNotice of AGM
17th Oct 20187:00 amRNSAudited results for the year ended 30 June 2018
8th Oct 20182:05 pmRNSSecond Price Monitoring Extn
8th Oct 20182:00 pmRNSPrice Monitoring Extension
8th Oct 20187:00 amRNSNew licence agreement with TDK
5th Oct 20188:00 amRNSNotice of Results
25th Sep 201810:22 amRNSSpire Health Tags launched in Apple stores
18th Jul 20188:30 amRNSDirector/PDMR Shareholding
13th Jul 20187:00 amRNSExercise of share options
22nd Jun 20187:00 amRNSIssue of Shares and Director/PDMR Shareholdings
21st Jun 20187:00 amRNSExercise of share options & PDMR shareholding
20th Jun 20187:00 amRNSTrading update
1st May 20187:00 amRNSExercise of employee share options
11th Apr 20187:00 amRNSDeveloping first 3V thin prismatic supercapacitors
6th Mar 20182:25 pmRNSInterim Results (Replacement)
6th Mar 20187:00 amRNSInterim Results
15th Feb 20188:46 amRNSNotice of results
16th Jan 20187:00 amRNSHolding(s) in Company
18th Dec 201711:42 amRNSGrant of Share Options
12th Dec 201710:35 amRNSIssue of Shares and Director/PDMR Shareholdings
23rd Nov 20179:40 amRNSResult of AGM and Chairman's AGM statement
20th Nov 20177:00 amRNSSpire launches Thinline enabled wearable
30th Oct 20177:00 amRNSNotice of AGM
9th Oct 20177:00 amRNSAudited results for the year ended 30 June 2017
22nd Sep 20178:59 amRNSHolding(s) in Company
22nd Sep 20177:00 amRNSNotice of Results
23rd Aug 20178:37 amRNSHolding(s) in Company
15th Aug 20177:00 amRNSFirst high-volume order for Thinline
29th Jun 20178:22 amRNSIssue of Shares and Director/PDMR Shareholdings
7th Jun 20177:00 amRNSTrading update for year ending 30 June 2017
25th May 20178:51 amRNSExtension of option term and Director/PDMR dealing
19th Apr 20178:47 amRNSHolding(s) in Company
20th Mar 20177:00 amRNSInterim Results
9th Mar 20177:00 amRNSCAP-XX launches new cylindrical supercapacitors
1st Feb 20177:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.